HYPERLIPIDEMIA

This study tests a new medicine, HRS-7249, to see if it can safely lower high levels of fats called triglycerides in the blood. About 200 adults with hyperlipidemia will receive either the drug or a placebo. The goal is to find the best dose and check for side effects.

This large study will test if a mobile digital health platform helps people better control high blood pressure, blood sugar, and cholesterol—known as the 'three highs'—to prevent heart and kidney disease. About 4,162 adults in New Taipei City will use the platform to track their …

This study tests a new medicine called HRS-1301 for people with high cholesterol (dyslipidemia). About 189 adults will receive either the drug or a placebo for 12 weeks to see how well it lowers bad cholesterol and if it is safe. The goal is to find the best dose for future use.

This study is testing a smartphone mini-program that gives personalized exercise plans to people with high blood pressure, high blood sugar, high cholesterol, and high uric acid (the 'Four Highs'). Researchers want to see if using the app for six months helps people become more a…

This study tests whether adding a new medicine called enlicitide decanoate to a standard cholesterol drug (rosuvastatin) lowers bad cholesterol more than a placebo. About 975 adults with high cholesterol will take either the combination or a placebo for 8 weeks. The main goal is …

This study tests a new medicine called SHR-1918 in 900 adults with high cholesterol and high triglycerides. Participants must already be on statins. The goal is to see if SHR-1918 can further lower bad cholesterol and fats in the blood compared to a placebo. This is a Phase 3 tri…

This study tests whether a team of doctors and nurses using a special algorithm can lower 'bad' cholesterol more effectively than usual care in 100 adults with heart or blood vessel disease. Participants will be randomly assigned to the new approach or standard treatment. The goa…

This study tests whether checking cholesterol often and quickly adjusting medication helps people with heart disease reach their cholesterol goals. About 1000 adults with high cholesterol and heart disease will be followed for a year. The goal is to see if this active approach lo…

This study tests a new drug called COR-1004, given as a single shot, to see if it is safe for people with high LDL (bad) cholesterol. About 60 healthy volunteers with LDL over 100 mg/dL who are not on cholesterol meds will be randomly assigned to get the drug or a placebo. Resear…

This study is testing whether a smartphone app powered by artificial intelligence can help people who have had heart bypass surgery or a stent procedure better control their blood pressure, diabetes, and cholesterol. About 536 adults who already have these conditions will use the…

This study tests a program called Inspire HER for Black women aged 30-79 with heart, kidney, and metabolic health issues. The program offers health education, physical activity, and social support to help lower heart disease risk. Researchers will see if the program is practical …

This study is testing whether using a smartwatch along with personalized digital health coaching can help people at risk for or with early-stage chronic conditions (like high blood pressure, prediabetes, or obesity) become more active and improve their health. About 1,700 adults …

This study tests if Ursodeoxycholic acid (UDCA) can prevent high blood sugar in people taking statins for high cholesterol. 128 adults aged 18-75 with high LDL but normal blood sugar will take either UDCA or a placebo with their statin for 6 months. Researchers will track changes…

This study looks at how a short course of high-dose statins affects fatty buildup (plaque) in the heart arteries of 140 people with mild blockages. Participants get either statins or a placebo for 3 months, and advanced CT scans track plaque changes. The goal is to understand who…

This study looks at how taking multiple medications affects the health of elderly people with chronic diseases like heart disease, diabetes, and high blood pressure. Researchers will survey 2000 patients aged 65 and older in Shaanxi Province, China, over two years. The goal is to…